<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31791419</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>25</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2051-5960</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Dec</Month><Day>02</Day></PubDate></JournalIssue><Title>Acta neuropathologica communications</Title><ISOAbbreviation>Acta Neuropathol Commun</ISOAbbreviation></Journal><ArticleTitle>Circadian sleep/wake-associated cells show dipeptide repeat protein aggregates in C9orf72-related ALS and FTLD cases.</ArticleTitle><Pagination><StartPage>189</StartPage><MedlinePgn>189</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">189</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40478-019-0845-9</ELocationID><Abstract><AbstractText>Motor-, behavior- and/or cognition-related symptoms are key hallmarks in patients with amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) with TDP-43 pathology (FTLD-TDP), respectively. It has been reported that these patients also experience sleep disturbances, which might implicate a disturbed circadian rhythm of the sleep/wake cycle. It remains unknown, however, whether cells involved in the circadian sleep/wake cycle are affected by ALS- and FTLD-related neuropathological changes including phosphorylated TDP-43 (pTDP-43) aggregates and dipeptide repeat protein (DPR) inclusions resulting from the C9orf72 hexanucleotide repeat expansion. Immunohistochemistry for DPR and pTDP-43 pathology was performed in post-mortem hypothalamus and pineal gland tissue of patients with ALS and/or FTLD-TDP with and without the C9orf72 repeat expansion and healthy controls. Circadian sleep/wake-associated cells, including pinealocytes and hypothalamic neurons related to the suprachiasmatic nucleus (SCN), were microscopically assessed. We observed numerous DPR inclusions (poly(GA), poly(GP), poly(GR) and poly(PR)) in the pinealocytes and few poly(GA) inclusions in the SCN-related neurons in C9orf72-related ALS and/or FTLD-TDP cases. These circadian sleep/wake-associated cells, however, were devoid of pTDP-43 pathology both in C9orf72- and nonC9orf72-related ALS and/or FTLD-TDP cases. Our neuropathological findings show that pinealocytes and, to a lesser extent, SCN-related neurons are affected by DPR pathology. This may reflect an involvement of these cells in sleep/wake disturbances observed in ALS and/or FTLD-TDP patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dedeene</LastName><ForeName>Lieselot</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-0545-8072</Identifier><AffiliationInfo><Affiliation>Department of Neurosciences, Laboratory for Molecular Neurobiomarker Research, KU Leuven (University of Leuven), Leuven Brain Institute (LBI), Leuven, Belgium. lieselot.dedeene@kuleuven.be.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Imaging and Pathology, Laboratory for Neuropathology, KU Leuven (University of Leuven), Leuven Brain Institute (LBI), Leuven, Belgium. lieselot.dedeene@kuleuven.be.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium. lieselot.dedeene@kuleuven.be.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosciences, Laboratory for Neurobiology, KU Leuven (University of Leuven) and Center for Brain &amp; Disease Research, VIB, Leuven Brain Institute (LBI), Leuven, Belgium. lieselot.dedeene@kuleuven.be.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Schoor</LastName><ForeName>Evelien</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Imaging and Pathology, Laboratory for Neuropathology, KU Leuven (University of Leuven), Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosciences, Laboratory for Neurobiology, KU Leuven (University of Leuven) and Center for Brain &amp; Disease Research, VIB, Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vandenberghe</LastName><ForeName>Rik</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosciences, Laboratory for Cognitive Neurology, KU Leuven, Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Damme</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Laboratory for Neurobiology, KU Leuven (University of Leuven) and Center for Brain &amp; Disease Research, VIB, Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poesen</LastName><ForeName>Koen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Laboratory for Molecular Neurobiomarker Research, KU Leuven (University of Leuven), Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thal</LastName><ForeName>Dietmar Rudolf</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Department of Imaging and Pathology, Laboratory for Neuropathology, KU Leuven (University of Leuven), Leuven Brain Institute (LBI), Leuven, Belgium. dietmar.thal@kuleuven.be.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, University Hospitals Leuven, Leuven, Belgium. dietmar.thal@kuleuven.be.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>1165119N</GrantID><Agency>Fonds Wetenschappelijk Onderzoek</Agency><Country>International</Country></Grant><Grant><GrantID>1S46219N</GrantID><Agency>Fonds Wetenschappelijk Onderzoek</Agency><Country>International</Country></Grant><Grant><GrantID>G0F8516N</GrantID><Agency>Fonds Wetenschappelijk Onderzoek</Agency><Country>International</Country></Grant><Grant><GrantID>C14-17-107</GrantID><Agency>KU Leuven</Agency><Country>International</Country></Grant><Grant><GrantID>IWT 135043</GrantID><Agency>Agentschap voor Innovatie door Wetenschap en Technologie</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Neuropathol Commun</MedlineTA><NlmUniqueID>101610673</NlmUniqueID><ISSNLinking>2051-5960</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568651">C9orf72 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004151">Dipeptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D066329">Protein Aggregates</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002940" MajorTopicYN="N">Circadian Rhythm</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042622" MajorTopicYN="N">DNA Repeat Expansion</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004151" MajorTopicYN="N">Dipeptides</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066329" MajorTopicYN="N">Protein Aggregates</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">C9orf72</Keyword><Keyword MajorTopicYN="N">Circadian rhythm</Keyword><Keyword MajorTopicYN="N">Dipeptide repeat proteins</Keyword><Keyword MajorTopicYN="N">Frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">Pineal gland</Keyword><Keyword MajorTopicYN="N">Sleep/wake cycle</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword></KeywordList><CoiStatement>RV&#x2019;s institution has a clinical trial agreement (RV as PI) with AbbVie (USA), Biogen (USA), Genentech (USA), Novartis (Switzerland), and Roche (Switzerland). PVD participated in advisory board meetings for Genzyme (USA), Pfizer (USA), Biogen (USA), Cytokinetics (USA), Mitsubishi Tanabe (Japan), CSL Behring (USA), Alexion Pharmaceuticals (USA). DRT received speaker honorary from Novartis Pharma AG (Switzerland), travel reimbursement from GE-Healthcare (UK) and UCB (BE), and collaborated with Novartis Pharma AG (Switzerland), Probiodrug (Germany), GE-Healthcare (UK), and Janssen Pharmaceutical Companies (Belgium).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31791419</ArticleId><ArticleId IdType="pmc">PMC6889626</ArticleId><ArticleId IdType="doi">10.1186/s40478-019-0845-9</ArticleId><ArticleId IdType="pii">10.1186/s40478-019-0845-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ahmed RM, Newcombe REA, Piper AJ, Lewis SJ, Yee BJ, Kiernan MC, Grunstein RR. Sleep disorders and respiratory function in amyotrophic lateral sclerosis. Sleep Med Rev. 2016;26:33&#x2013;42. doi: 10.1016/j.smrv.2015.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smrv.2015.05.007</ArticleId><ArticleId IdType="pubmed">26166297</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson KN, Hatfield C, Kipps C, Hastings M, Hodges JR. Disrupted sleep and circadian patterns in frontotemporal dementia. Eur J Neurol. 2009;16:317&#x2013;323. doi: 10.1111/j.1468-1331.2008.02414.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2008.02414.x</ArticleId><ArticleId IdType="pubmed">19170747</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash PEA, Bieniek KF, Gendron TF, Caulfield T, Lin W-L, DeJesus-Hernandez M, Van Blitterswijk MM, Jansen-West K, Paul JW, III, Rademakers R, Boylan KB, Dickson DW, Petrucelli L. Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron. 2013;77:639&#x2013;646. doi: 10.1016/j.neuron.2013.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.02.004</ArticleId><ArticleId IdType="pmc">PMC3593233</ArticleId><ArticleId IdType="pubmed">23415312</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R, Isaacs AM. C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat Rev Neurol. 2018;14:544&#x2013;558. doi: 10.1038/s41582-018-0047-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0047-2</ArticleId><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Del Tredici K, R&#xfc;b U, de Vos RAI, Jansen Steur ENH, Braak E. Staging of brain pathology related to sporadic Parkinson&#x2019;s disease. Neurobiol Aging. 2003;24:197&#x2013;211. doi: 10.1016/S0197-4580(02)00065-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0197-4580(02)00065-9</ArticleId><ArticleId IdType="pubmed">12498954</ArticleId></ArticleIdList></Reference><Reference><Citation>Breen DP, Vuono R, Nawarathna U, Fisher K, Shneerson JM, Reddy AB, Barker RA. Sleep and circadian rhythm regulation in early parkinson disease. JAMA Neurol. 2014;71:589&#x2013;595. doi: 10.1001/jamaneurol.2014.65.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.65</ArticleId><ArticleId IdType="pmc">PMC4119609</ArticleId><ArticleId IdType="pubmed">24687146</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Del Tredici K, Toledo JB, Robinson JL, Irwin DJ, Grossman M, Suh E, Van Deerlin VM, Wood EM, Baek Y, Kwong L, Lee EB, Elman L, Mccluskey L, Fang L, Feldengut S, Ludolph AC, Lee VM, Braak H, Trojanowski JQ. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol. 2013;74:20&#x2013;38. doi: 10.1002/ana.23937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23937</ArticleId><ArticleId IdType="pmc">PMC3785076</ArticleId><ArticleId IdType="pubmed">23686809</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL, For the World Federation of Neurology Research Group on Motor Neuron Diseases El Escorial revisited : revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Congiu P, Mariani S, Milioli G, Parrino L, Tamburrino L, Borghero G, Defazio G, Pereira B, Fantini M, Puligheddu M (2019) Sleep cardiac dysautonomia and EEG oscillations in amyotrophic lateral sclerosis. Sleep 42. 10.1093/sleep/zsz164</Citation><ArticleIdList><ArticleId IdType="pubmed">31312838</ArticleId></ArticleIdList></Reference><Reference><Citation>Cykowski MD, Dickson DW, Powell SZ, Arumanayagam AS, Rivera AL, Appel SH. Dipeptide repeat (DPR) pathology in the skeletal muscle of ALS patients with C9ORF72 repeat expansion. Acta Neuropathol. 2019;138:667&#x2013;670. doi: 10.1007/s00401-019-02050-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-02050-8</ArticleId><ArticleId IdType="pmc">PMC6778061</ArticleId><ArticleId IdType="pubmed">31375896</ArticleId></ArticleIdList></Reference><Reference><Citation>Cykowski MD, Takei H, Schulz PE, Appel SH, Powell SZ. TDP-43 pathology in the basal forebrain and hypothalamus of patients with amyotrophic lateral sclerosis. Acta Neuropathol Commun. 2014;2:171. doi: 10.1186/s40478-014-0171-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-014-0171-1</ArticleId><ArticleId IdType="pmc">PMC4297460</ArticleId><ArticleId IdType="pubmed">25539830</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai J, Swaab DF, Buijs RM. Distribution of vasopressin and vasoactive intestinal polypeptide (VIP) fibers in the human hypothalamus with special emphasis on suprachiasmatic nucleus efferent projections. J Comp Neurol. 1997;383:397&#x2013;414. doi: 10.1002/(sici)1096-9861(19970714)383:4&lt;397::aid-cne1&gt;3.0.co;2-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(sici)1096-9861(19970714)383:4&lt;397::aid-cne1&gt;3.0.co;2-y</ArticleId><ArticleId IdType="pubmed">9208989</ArticleId></ArticleIdList></Reference><Reference><Citation>Daoud H, Postuma RB, Bourassa CV, Rochefort D, Gauthier MT, Montplaisir J, Gagnon J, Arnulf I, Dauvilliers Y, Charley CM, Inoue Y, Sasai T, H&#xf6;gl B, Desautels A, Frauscher B, Cochen De Cock V, Rouleau GA, Dion PA. C9orf72 repeat expansions in rapid eye movement sleep behaviour disorder. Can J Neurol Sci. 2014;41:759&#x2013;762. doi: 10.1017/cjn.2014.39.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/cjn.2014.39</ArticleId><ArticleId IdType="pubmed">25377888</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson Y, Robinson AC, Liu X, Wu D, Troakes C, Rollinson S, Masuda-Suzukake M, Suzuki G, Nonaka T, Shi J, Tian J, Hamdalla H, Ealing J, Richardson A, Jones M, Pickering-Brown S, Snowden JS, Hasegawa M, Mann DMA. Neurodegeneration in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9orf72 is linked to TDP-43 pathology and not associated with aggregated forms of dipeptide repeat proteins. Neuropathol Appl Neurobiol. 2016;42:242&#x2013;254. doi: 10.1111/nan.12292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12292</ArticleId><ArticleId IdType="pmc">PMC4832296</ArticleId><ArticleId IdType="pubmed">26538301</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho M, Dengler R, Eisen A, England JD, Kaji R, Kimura J, Mills K, Mitsumoto H, Nodera H, Shefner J, Swash M. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol. 2008;119:497&#x2013;503. doi: 10.1016/j.clinph.2007.09.143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2007.09.143</ArticleId><ArticleId IdType="pubmed">18164242</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho M, Swash M. Awaji diagnostic algorithm increases sensitivity of El Escorial criteria for ALS diagnosis. Amyotroph Lateral Scler. 2009;10:53&#x2013;57. doi: 10.1080/17482960802521126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960802521126</ArticleId><ArticleId IdType="pubmed">18985466</ArticleId></ArticleIdList></Reference><Reference><Citation>De Pablo-Fern&#xe1;ndez E, Courtney R, Warner TT, Holton JL. A histologic study of the circadian system in Parkinson disease, multiple system atrophy, and progressive Supranuclear palsy. JAMA Neurol. 2018;75:1008&#x2013;1012. doi: 10.1001/jamaneurol.2018.0640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2018.0640</ArticleId><ArticleId IdType="pmc">PMC6142937</ArticleId><ArticleId IdType="pubmed">29710120</ArticleId></ArticleIdList></Reference><Reference><Citation>Debray Sarah, Race Val&#xe9;rie, Crabb&#xe9; Veerle, Herdewyn Sarah, Matthijs Gert, Goris An, Dubois B&#xe9;n&#xe9;dicte, Thijs Vincent, Robberecht Wim, Van Damme Philip. Frequency of C9orf72 repeat expansions in amyotrophic lateral sclerosis: a Belgian cohort study. Neurobiology of Aging. 2013;34(12):2890.e7-2890.e12. doi: 10.1016/j.neurobiolaging.2013.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.06.009</ArticleId><ArticleId IdType="pubmed">23870417</ArticleId></ArticleIdList></Reference><Reference><Citation>Dedeene L, Van Schoor E, Race V, Moisse M, Vandenberghe R, Poesen K, Van Damme P, Thal DR. An ALS case with 38 (G4C2)-repeats in the C9orf72 gene shows TDP-43 and sparse dipeptide repeat protein pathology. Acta Neuropathol. 2019;137:855&#x2013;858. doi: 10.1007/s00401-019-01996-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-01996-z</ArticleId><ArticleId IdType="pubmed">30919029</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-Abad M, Buczyner J, Venza B, Scharf S, Kwan J, Lubinski B, Russell J. Poor sleep quality in patients with amyotrophic lateral sclerosis at the time of diagnosis. J Clin Neuromuscul Dis. 2018;20:60&#x2013;68. doi: 10.1097/CND.0000000000000234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CND.0000000000000234</ArticleId><ArticleId IdType="pubmed">30439751</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, Ogar JM, Rohrer JD, Black S, Boeve BF, Manes F, Dronkers NF, Vandenberghe R, Rascovsky K, Patterson K, Miller BL, Knopman DS, Hodges JR, Mesulam MM, Grossman M. Classification of primary progressive aphasia and its variants. Neurology. 2011;76:1006&#x2013;1014. doi: 10.1212/WNL.0b013e31821103e6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31821103e6</ArticleId><ArticleId IdType="pmc">PMC3059138</ArticleId><ArticleId IdType="pubmed">21325651</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Z, Liu Q, Peng Y, Dai J, Xie Y, Chen W, Long S, Pei Z, Su H, Yao X. Circadian rhythm dysfunction accelerates disease progression in a mouse model with amyotrophic lateral sclerosis. Front Neurol. 2018;9:218. doi: 10.3389/fneur.2018.00218.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00218</ArticleId><ArticleId IdType="pmc">PMC5928145</ArticleId><ArticleId IdType="pubmed">29740382</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Thies B, Trojanowski JQ, Vinters HV, Montine TJ. National Institute on Aging &#x2013; Alzheimer &#x2019; s association guidelines for the neuropathologic assessment of Alzheimer&#x2019;s disease. Alzheimers Dement. 2012;8:1&#x2013;13. doi: 10.1016/j.jalz.2011.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2011.10.007</ArticleId><ArticleId IdType="pmc">PMC3266529</ArticleId><ArticleId IdType="pubmed">22265587</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, Huang Y, Tai H, Zhang K, Wang Z, Shen D, Fu H, Su N, Shi J, Ding Q, Liu M, Guan Y, Gao J, Cui L. Excessive daytime sleepiness in Chinese patients with sporadic amyotrophic lateral sclerosis and its association with cognitive and behavioural impairments. J Neurol Neurosurg Psychiatry. 2018;89:1038&#x2013;1043. doi: 10.1136/jnnp-2018-318810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-318810</ArticleId><ArticleId IdType="pubmed">30045943</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo Coco D, Mattaliano P, Spataro R, Mattaliano A, La Bella V. Sleep - wake disturbances in patients with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2011;82:839&#x2013;842. doi: 10.1136/jnnp.2010.228007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.228007</ArticleId><ArticleId IdType="pubmed">21217159</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IRA, Frick P, Gr&#xe4;sser FA, Gendron TF, Petrucelli L, Cashman NR, Edbauer D, Kremmer E, Prudlo J, Troost D, Neumann M. Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers. Acta Neuropathol. 2015;130:845&#x2013;861. doi: 10.1007/s00401-015-1476-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1476-2</ArticleId><ArticleId IdType="pubmed">26374446</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IRA, Neumann M, Bigio EH, Cairns NJ, Alafuzoff I, Kril J, Kovacs GG, Ghetti B, Halliday G, Holm IE, Ince PG, Kamphorst W, Revesz T, Rozemuller AJM, Kumar-Singh S, Akiyama H, Baborie A, Spina S, Dickson DW, Trojanowski JQ, Mann DMA. Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations. Acta Neuropathol. 2009;117:15&#x2013;18. doi: 10.1007/s00401-008-0460-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0460-5</ArticleId><ArticleId IdType="pmc">PMC2710877</ArticleId><ArticleId IdType="pubmed">19015862</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarter SJ, St. Louis EK, Boeve BF. Sleep Disturbances in Frontotemporal Dementia. Curr Neurol Neurosci Rep. 2016;16:85. doi: 10.1007/s11910-016-0680-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-016-0680-3</ArticleId><ArticleId IdType="pubmed">27485946</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok K, Traynor BJ, Schymick J, Tienari PJ, Laaksovirta H, Peuralinna T, Myllykangas L, Chi&#xf2; A, Shatunov A, Boeve BF, Boxer AL, DeJesus-Hernandez M, Mackenzie IR, Waite A, Williams N, Morris HR, Sim&#xf3;n-S&#xe1;nchez J, van Swieten JC, Heutink P, Restagno G, Mora G, Morrison KE, Shaw PJ, Rollinson PS, Al-Chalabi A, Rademakers R, Pickering-Brown S, Orrell RW, Nalls MA, Hardy J. The chromosome 9 ALS and FTD locus is probably derived from a single founder. Neurobiol Aging. 2012;33(209):e3&#x2013;209.e8. doi: 10.1016/j.neurobiolaging.2011.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2011.08.005</ArticleId><ArticleId IdType="pmc">PMC3312749</ArticleId><ArticleId IdType="pubmed">21925771</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K, Weng S-M, Arzberger T, May S, Rentzsch K, Kremmer E, Schmid B, Kretzschmar HA, Cruts M, Van Broeckhoven C, Haass C, Edbauer D. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science. 2013;339:1335&#x2013;1338. doi: 10.1126/science.1232927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1232927</ArticleId><ArticleId IdType="pubmed">23393093</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM-Y. Ubiquitinated TDP-43 in Frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Pardo CA, Martin LJ, Troncoso JC, Price DL. The human pineal gland in aging and Alzheimer&#x2019;s disease: patterns of cytoskeletal antigen immunoreactivity. Acta Neuropathol. 1990;80:535&#x2013;540. doi: 10.1007/bf00294615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/bf00294615</ArticleId><ArticleId IdType="pubmed">2251911</ArticleId></ArticleIdList></Reference><Reference><Citation>Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, van Swieten JC, Seelaar H, Dopper EGP, Onyike CU, Hillis AE, Josephs K, Boeve B, Kertesz A, Seeley W, Rankin K, Johnson J, Gorno-Tempini M, Rosen H, Prioleau-Latham C, Lee A, Kipps C, Lillo P, Piguet O, Rohrer J, Rossor M, Warren J, Fox N, Galasko D, Salmon D, Black S, Mesulam M, Weintraub S, Dickerson B, Diehl-Schmid J, Pasquier F, Deramecourt V, Lebert F, Pijnenburg Y, Chow T, Manes F, Grafman J, Cappa S, Freedman M, Grossman M, Miller B. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134:2456&#x2013;2477. doi: 10.1093/brain/awr179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr179</ArticleId><ArticleId IdType="pmc">PMC3170532</ArticleId><ArticleId IdType="pubmed">21810890</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chi&#xf2; A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci. 2014;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Schludi MH, May S, Gr&#xe4;sser FA, Rentzsch K, Kremmer E, K&#xfc;pper C, Klopstock T, German Consortium for Frontotemporal Lobar Degeneration, Bavarian Brain Banking Alliance. Arzberger T, Edbauer D. Distribution of dipeptide repeat proteins in cellular models and C9orf72 mutation cases suggests link to transcriptional silencing. Acta Neuropathol. 2015;130:537&#x2013;555. doi: 10.1007/s00401-015-1450-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1450-z</ArticleId><ArticleId IdType="pmc">PMC4575390</ArticleId><ArticleId IdType="pubmed">26085200</ArticleId></ArticleIdList></Reference><Reference><Citation>Stopa EG, Volicer L, Kuo-Leblanc V, Harper D, Lathi D, Tate B, Satlin A. Pathologic evaluation of the human suprachiasmatic nucleus in severe dementia. J Neuropathol Exp Neurol. 1999;58:29&#x2013;39. doi: 10.1097/00005072-199901000-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-199901000-00004</ArticleId><ArticleId IdType="pubmed">10068311</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B, Bento-Abreu A, Gendron TF, Boeynaems S, Bogaert E, Nuyts R, Timmers M, Scheveneels W, Hersmus N, Wang J, Mizielinska S, Isaacs AM, Petrucelli L, Lemmens R, Van Damme P, Van Den Bosch L, Robberecht W. A zebrafish model for C9orf72 ALS reveals RNA toxicity as a pathogenic mechanism. Acta Neuropathol. 2018;135:427&#x2013;443. doi: 10.1007/s00401-017-1796-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1796-5</ArticleId><ArticleId IdType="pubmed">29302778</ArticleId></ArticleIdList></Reference><Reference><Citation>Videnovic A, Noble C, Reid KJ, Peng J, Turek FW, Marconi A, Rademaker AW, Simuni T, Zadikoff C, Zee PC. Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease. JAMA Neurol. 2014;71:463&#x2013;469. doi: 10.1001/jamaneurol.2013.6239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2013.6239</ArticleId><ArticleId IdType="pmc">PMC4078989</ArticleId><ArticleId IdType="pubmed">24566763</ArticleId></ArticleIdList></Reference><Reference><Citation>Vrijsen B, Buyse B, Belge C, Robberecht W, Van Damme P, Decramer M, Testelmans D. Noninvasive ventilation improves sleep in amyotrophic lateral sclerosis: a prospective Polysomnographic study. J Clin Sleep Med. 2015;11:559&#x2013;566. doi: 10.5664/jcsm.4704.</Citation><ArticleIdList><ArticleId IdType="doi">10.5664/jcsm.4704</ArticleId><ArticleId IdType="pmc">PMC4410930</ArticleId><ArticleId IdType="pubmed">25766713</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y-H, Swaab DF. The human pineal gland and melatonin in aging and Alzheimer&#x2019;s disease. J Pineal Res. 2005;38:145&#x2013;152. doi: 10.1111/j.1600-079X.2004.00196.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-079X.2004.00196.x</ArticleId><ArticleId IdType="pubmed">15725334</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T, Jiang X, Xu M, Wang H, Sang X, Qin M, Bao P, Wang R, Zhang C, Lu H, Li Y, Ren J, Chang H-C, Yan J, Sun Q, Xu J. Sleep and circadian abnormalities precede cognitive deficits in R521C FUS knockin rats. Neurobiol Aging. 2018;72:159&#x2013;170. doi: 10.1016/j.neurobiolaging.2018.08.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.08.025</ArticleId><ArticleId IdType="pubmed">30273830</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J-N, Liu R-Y, Kamphorst W, Hofman MA, Swaab DF. Early neuropathological Alzheimer&#x2019;s changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels. J Pineal Res. 2003;35:125&#x2013;130. doi: 10.1034/j.1600-079X.2003.00065.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1600-079X.2003.00065.x</ArticleId><ArticleId IdType="pubmed">12887656</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>